Baylor College of Medicine to conduct Phase 3 trials for investigational COVID-19 vaccine

The Vaccine and Treatment Evaluation Unit of the Baylor College of Medicine is one of 90 sites selected to participate in the Phase 3 clinical trials for Moderna Inc.’s investigational mRNA-1273 vaccine.